Pope Leo pledges gradual return to duties in first event since cancer surgery
Pope Leo has made a public return following cancer surgery, pledging a gradual resumption of duties.
35 trends tracked about this subject — the full history, oldest to newest below.
Pope Leo has made a public return following cancer surgery, pledging a gradual resumption of duties.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Pope Leo returns to the Vatican just four days after undergoing surgery for lung cancer.
13 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Coverage examines the diagnosis of lung cancer called adenocarcinoma for Pope Leo XIV, creating uncertainty within the Vatican.
4 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Recent reporting across major outlets highlights new scientific studies examining dietary patterns and biological markers in large adult cohorts.
18 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Pope Leo XIV has been diagnosed with lung cancer following surgery to remove a nodule, according to the Vatican and global media reports.
Recent scientific studies and medical reports examine a preinvasive regulatory T cell axis and immune fog for lung cancer interception.
Recent coverage highlights new evidence regarding exercise safety for lung cancer patients undergoing chemotherapy.
Merck and Daiichi Sankyo pull their US lung cancer drug application following regulatory pushback.
A biotech startup run by thousands of AI agents discovers a promising lung-cancer drug, sparking global attention.
Coverage highlights a rare genetic mutation linked to significantly higher lung cancer risks in non-smokers.
Coverage explores how a team of artificial intelligence models successfully discovered a promising new drug for lung cancer.
A newly reported protein-based MRI agent achieves earlier detection of lung cancer and hidden metastases without radiation.
A new study involving a Greek cohort reveals that lung cancer patients carry a significantly higher burden of microplastic particles in their lungs.
New scientific research indicates a concerning link between the presence and quantity of microplastics in the lungs and lung cancer diagnoses.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The FDA has approved daraxonrasib for the treatment of previously treated RAS-mutant non-small-cell lung cancer and pancreatic cancer.
Medical experts and news outlets are highlighting the critical need for early lung cancer screening to combat the disease's tendency to remain silent for years.
AstraZeneca ends a Phase 3 lung cancer drug trial for volrustomig after a formal review determines success is unlikely.
Recent coverage examines rising lung cancer diagnoses among non-smokers, highlighting hidden environmental risks and screening gaps.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Oncologists warn that vaping may be creating a new wave of lung cancer, challenging the perception that e-cigarettes are a safer alternative to smoking.
Medical reports highlight a growing health crisis as lung cancer rates rise among women and young adults who have never smoked cigarettes.
Medical experts are investigating a rise in lung cancer among healthy non-smokers under 50, focusing on a specific 'red zone' diet and food ingredients.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
A high-profile study on the timing of lung cancer immunotherapy has been retracted by Nature Medicine following a four-month investigation.
Medical researchers are exploring a new paradigm in oncology through early-detection blood tests and potential preventative drug treatments.
New diagnostic methods, including blood-based testing, are emerging as potential tools for the early detection and prevention of lung cancer.